4.735
Finanzdaten der Nuvation Bio Inc-Aktie (NUVB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
61.93%
31.69
|
83.23 | 41.87 | 13.12 | 4.833 |
|
|
4.25%
82.72
|
79.35 | 83.92 | 66.20 | 65.85 |
| Depreciation and Amortization |
0.00%
0.536
|
0.536 | 0.539 | 0.534 | 0.356 |
| Operating Income/Loss |
1,415%
-51.04
|
3.881 | -34.04 | -56.43 | -63.59 |
| Nonoperating Income/Loss |
878.63%
-11.80
|
1.516 | -2.555 | 0.642 | 4.582 |
| Income/Loss From Continuing Operations Before Tax |
1,264%
-62.84
|
5.397 | -36.59 | -55.79 | -59.01 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
1,264%
-62.84
|
5.397 | -36.59 | -55.79 | -59.01 |
| Basic Average Shares |
0.41%
0.3488
|
0.3473 | 0.000944 | 0.3424 | 0.3407 |
| Diluted Average Shares |
7.62%
0.3488
|
0.3775 | 0.000944 | 0.3424 | 0.3407 |
| Basic Earnings Per Share |
1,000.00%
-0.18
|
0.02 | -0.11 | -0.16 | -0.17 |
| Diluted Earnings Per Share |
1,900%
-0.18
|
0.01 | -0.11 | -0.16 | -0.17 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):